PortfoliosLab logoPortfoliosLab logo
VRTX vs. CS.PA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

VRTX vs. CS.PA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vertex Pharmaceuticals Incorporated (VRTX) and AXA SA (CS.PA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

VRTX is traded in USD, while CS.PA is traded in EUR. To make them comparable, the CS.PA values have been converted to USD using the latest available exchange rates.

Returns By Period

In the year-to-date period, VRTX achieves a -1.86% return, which is significantly lower than CS.PA's 4.12% return. Over the past 10 years, VRTX has outperformed CS.PA with an annualized return of 17.15%, while CS.PA has yielded a comparatively lower 14.28% annualized return.


VRTX

1D
-0.03%
1M
-1.22%
YTD
-1.86%
6M
-1.57%
1Y
-2.31%
3Y*
9.16%
5Y*
18.18%
10Y*
17.15%

CS.PA

1D
0.86%
1M
2.58%
YTD
4.12%
6M
5.67%
1Y
4.20%
3Y*
25.31%
5Y*
18.53%
10Y*
14.28%
*Multi-year figures are annualized to reflect compound growth (CAGR)

VRTX vs. CS.PA - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
VRTX
Vertex Pharmaceuticals Incorporated
-1.86%12.58%-1.03%40.90%31.50%-7.08%7.94%32.13%10.58%103.42%
CS.PA
AXA SA
4.12%42.62%15.89%24.04%-0.21%32.91%-12.08%38.36%-23.27%23.25%

Correlation

The correlation between VRTX and CS.PA is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.18

Correlation (3Y)
Calculated over the trailing 3-year period

0.15

Correlation (5Y)
Calculated over the trailing 5-year period

0.14

Correlation (10Y)
Calculated over the trailing 10-year period

0.11

Correlation (All Time)
Calculated using the full available price history since Jun 1, 2007

0.17

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

VRTX vs. CS.PA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VRTX
VRTX Risk / Return Rank: 3737
Overall Rank
VRTX Sharpe Ratio Rank: 3939
Sharpe Ratio Rank
VRTX Sortino Ratio Rank: 3434
Sortino Ratio Rank
VRTX Omega Ratio Rank: 3535
Omega Ratio Rank
VRTX Calmar Ratio Rank: 3838
Calmar Ratio Rank
VRTX Martin Ratio Rank: 3737
Martin Ratio Rank

CS.PA
CS.PA Risk / Return Rank: 4545
Overall Rank
CS.PA Sharpe Ratio Rank: 4949
Sharpe Ratio Rank
CS.PA Sortino Ratio Rank: 4040
Sortino Ratio Rank
CS.PA Omega Ratio Rank: 4141
Omega Ratio Rank
CS.PA Calmar Ratio Rank: 4949
Calmar Ratio Rank
CS.PA Martin Ratio Rank: 4848
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VRTX vs. CS.PA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Vertex Pharmaceuticals Incorporated (VRTX) and AXA SA (CS.PA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


VRTXCS.PADifference
Sharpe ratioReturn per unit of total volatility

-0.25

Sortino ratioReturn per unit of downside risk

-0.23

Omega ratioGain probability vs. loss probability

1.02

1.05

-0.03

Calmar ratioReturn relative to maximum drawdown

-0.14

0.22

-0.36

Martin ratioReturn relative to average drawdown

-0.29

0.40

-0.69

VRTX vs. CS.PA - Sharpe Ratio Comparison

The current VRTX Sharpe Ratio is -0.10, which is lower than the CS.PA Sharpe Ratio of 0.15. The chart below compares the historical Sharpe Ratios of VRTX and CS.PA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

VRTX vs. CS.PA - Drawdown Comparison

The maximum VRTX drawdown since its inception was -91.77%, which is greater than CS.PA's maximum drawdown of -79.24%. Use the drawdown chart below to compare losses from any high point for VRTX and CS.PA.


Loading charts...

Drawdown Indicators


VRTXCS.PADifference

Max Drawdown

Largest peak-to-trough decline

-91.77%

-79.24%

-12.53%

Max Drawdown (1Y)

Largest decline over 1 year

-23.56%

-14.59%

-8.97%

Max Drawdown (3Y)

Largest decline over 3 years

-29.07%

-16.15%

-12.92%

Max Drawdown (5Y)

Largest decline over 5 years

-29.07%

-32.50%

+3.43%

Max Drawdown (10Y)

Largest decline over 10 years

-41.60%

-55.59%

+13.99%

Current Drawdown

Current decline from peak

-13.90%

-1.39%

-12.51%

Average Drawdown

Average peak-to-trough decline

-37.73%

-19.05%

-18.68%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.30%

8.21%

+3.09%

Volatility

VRTX vs. CS.PA - Volatility Comparison

Vertex Pharmaceuticals Incorporated (VRTX) has a higher volatility of 7.47% compared to AXA SA (CS.PA) at 4.98%. This indicates that VRTX's price experiences larger fluctuations and is considered to be riskier than CS.PA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


VRTXCS.PADifference

Volatility (1M)

Calculated over the trailing 1-month period

7.47%

4.98%

+2.49%

Volatility (6M)

Calculated over the trailing 6-month period

20.71%

15.18%

+5.53%

Volatility (1Y)

Calculated over the trailing 1-year period

34.13%

21.03%

+13.10%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

28.53%

23.84%

+4.69%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

32.82%

26.67%

+6.15%

Dividends

VRTX vs. CS.PA - Dividend Comparison

VRTX has not paid dividends to shareholders, while CS.PA's dividend yield for the trailing twelve months is around 5.68%.


PositionTTM20252024202320222021202020192018201720162015
CS.PA
AXA SA
5.68%5.25%5.77%5.76%5.91%5.46%3.74%5.34%6.68%4.69%4.59%3.77%
VRTX
Vertex Pharmaceuticals Incorporated
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

VRTX vs. CS.PA - Financials Comparison

This section allows you to compare key financial metrics between Vertex Pharmaceuticals Incorporated and AXA SA. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Please note, different currencies. VRTX values in USD, CS.PA values in EUR

Frequently Asked Questions


VRTX and CS.PA have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for VRTX and CS.PA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer